Mpox vaccine maker says ‘better prepared’ than in 2022

Danish drugmaker Bavarian Nordic said last week that it was ready to supply up to 10 million doses of its vaccine targeting mpox by the end of 2025. Danish drugmaker Bavarian Nordic said Thursday that it was “better prepared” to supply its mpox vaccine for the current surge of the virus than it was for the 2022 epidemic. The vaccine maker said last week that it was ready to supply up to 10 million doses of its vaccine targeting mpox by the end of 2025, with some 500,000 doses currently in stock. According to the company, the level of “panic Read More